The WT1 Wilms' tumor suppressor gene is a downstream target for insulin-like growth factor-I (IGF-I) action in PC12 cells

Journal of Neurochemistry

Volumn 99, Issue 3, 2006, Pages 818-826

  Sarfstein, Rive ^a   Werner, Haim ^a  

^a TEL AVIV UNIVERSITY   (Israel)

Author keywords

Insulin like growth factor I; Insulin like growth factor I receptor; PC12 cells; Wilms' tumor; WT1

Indexed keywords

2 MORPHOLINO 8 PHENYLCHROMONE; ANTISENSE OLIGONUCLEOTIDE; FLUORESCEIN ISOTHIOCYANATE; LIPOCORTIN 5; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE INHIBITOR; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE; PHOSPHATIDYLINOSITOL 3 KINASE; PHOSPHATIDYLINOSITOL 3 KINASE INHIBITOR; PROTEIN BAX; PROTEIN KINASE B; RAF PROTEIN; RAS PROTEIN; SOMATOMEDIN B; SOMATOMEDIN C; SOMATOMEDIN C RECEPTOR; UO 126; WT1 PROTEIN;

APOPTOSIS; ARTICLE; CELL DIFFERENTIATION; CELL PROLIFERATION; CELL STRAIN; CONTROLLED STUDY; CORRELATION ANALYSIS; DNA TRANSFECTION; HUMAN; HUMAN CELL; ONCOGENE RAS; PRIORITY JOURNAL; PROMOTER REGION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; TUMOR SUPPRESSOR GENE;

1-PHOSPHATIDYLINOSITOL 3-KINASE; ANIMALS; ANNEXIN A5; APOPTOSIS; BCL-2-ASSOCIATED X PROTEIN; BLOTTING, WESTERN; DOSE-RESPONSE RELATIONSHIP, DRUG; GENE EXPRESSION REGULATION; INSULIN-LIKE GROWTH FACTOR I; MITOGEN-ACTIVATED PROTEIN KINASES; PC12 CELLS; PHOSPHATIDYLINOSITOL 3-KINASES; POLY(ADP-RIBOSE) POLYMERASES; RATS; RNA, MESSENGER; SIGNAL TRANSDUCTION; TRANSFECTION; WT1 PROTEINS;

EID: 33750050806     PISSN: 00223042     EISSN: 14714159     Source Type: Journal    
DOI: 10.1111/j.1471-4159.2006.04119.x     Document Type: Article

References (51)

1. Alnemri E. S., Livingston D. J., Nicholson D. W., Salvesen G., Thornberry N. A., Wong W. W. and Yuan J. (1996) Human ICE/CED-3 protease nomenclature. Cell 87, 171.
2. Arsenijevic Y. and Weiss S. (1998) Insulin-like growth factor-I is a differentiation factor for postmitotic CNS stem cell-derived neuronal precursors: distinct actions from those of brain-derived neurotrophic factor. J. Neurosci. 18, 2118-2128.
3. Call K. M., Glaser T., Ito C. Y. et al. (1990) Isolation and characterization of a zinc finger polypeptide gene at the human chromosome 11 Wilms' tumor locus. Cell 60, 509-520.
4. D'Arcangelo G. and Halegoua S. (1993) A branched signaling pathway for nerve growth factor is revealed by Src-, Ras-, and Raf-mediated gene inductions. Mol. Cell Biol. 13, 3146-3155.
5. Dennis S. L., Manji S. S., Carrington D. P., Scarcella D. L., Ashley D. M., Smith P. J. and Algar E. M. (2002) Expression and mutation analysis of the Wilms' tumor 1 gene in human neural tumors. Int. J. Cancer 97, 713-715.
6. Dews M., Prisco M., Peruzz F., Romano G., Morrione A. and Baserga R. (2000) Domains of the insulin-like growth factor I receptor required for the activation of extracellular signal-regulated kinases. Endocrinology 141, 1289-1300.
7. Dore S., Kar S. and Quirion R. (1997) Insulin-like growth factor I protects and rescues hippocampal neurons against beta-amyloid- and human amylin-induced toxicity. Proc. Natl Acad. Sci. USA 94, 4772-4777.
8. Dupont J., Dunn S. E., Barrett J. C. and LeRoith D. (2003) Microarray analysis and identification of novel molecules involved in insulin-like growth factor-1 receptor signaling and gene expression. Recent Prog. Horm. Res. 58, 325-342.
9. Eigenmann J. E., Amador A. and Patterson D. F. (1988) Insulin-like growth factor I levels in proportionate dogs, chondrodystrophic dogs and in giant dogs. Acta Endocrinol. 118, 105-108.
10. Englert C., Hou X., Maheswaran S., Bennett P., Ngwu C., Re G. G., Garvin A. J., Rosner M. R. and Haber D. A. (1995) WT1 suppresses synthesis of the epidermal growth factor receptor and induces apoptosis. EMBO J. 14, 4662-4675.
11. Englert C., Maheswaran S., Garvin A. J., Kreidberg J. and Haber D. A. (1997) Induction of p21 by the Wilms' tumor suppressor gene WT1. Cancer Res. 57, 1429-1434.
12. Feldman E. L., Sullivan K. A., Kim B. and Russell J. W. (1997) Insulin-like growth factors regulate neuronal differentiation and survival. Neurobiol. Dis. 4, 201-214.
13. Forbes B. E., Hartfield P. J., McNeil K. A., Surinya K. H., Milner S. J., Cosgrove L. J. and Wallace J. C. (2002) Characteristics of binding of insulin-like growth factor (IGF)-I and IGF-II analogues to the type 1 IGF receptor determined by BIAcore analysis. Eur. J. Biochem. 269, 961-968.
14. Garcia-Segura L. M., Perez J., Pons S., Rejas M. T. and Torres-Aleman I. (1991) Localization of insulin-like growth factor I (IGF-I)-like immunoreactivity in the developing and adult rat brain. Brain Res. 560, 167-174.
15. Gashler A. L., Bonthron D. T., Madden S. L., Rauscher F. J. III, Collins T. and Sukhatme V. P. (1992) Human platelet-derived growth factor A chain is transcriptionally repressed by the Wilms tumor suppressor WT1. Proc. Natl Acad. Sci. USA 89, 10 984-10 988.
16. Gessler M., Poustka A., Cavenee W., Neve R. L., Orkin S. H. and Bruns G. A. (1990) Homozygous deletion in Wilms tumours of a zinc-finger gene identified by chromosome jumping. Nature 343, 774-778.
17. Hallak H., Ramadan B. and Rubin R. (2001) Tyrosine phosphorylation of insulin receptor substrate-1 (IRS-1) by oxidant stress in cerebellar granule neurons: modulation by N-methyl-D-aspartate through calcineurin activity. J. Neurochem. 77, 63-70.
18. Hewitt S. M., Hamada S., McDonnell T. J., Rauscher F. J. III and Saunders G. F. (1995) Regulation of the proto-oncogenes bcl-2 and c-myc by the Wilms' tumor suppressor gene WT1. Cancer Res. 55, 5386-5389.
19. Idelman G., Glaser T., Roberts C. T. and Werner H. Jr (2003) WT1-p53 interactions in IGF-I receptor gene regulation. J. Biol. Chem. 278, 3474-3482.
20. Jacobson M. D., Weil M. and Raff M. C. (1997) Programmed cell death in animal development. Cell 88, 347-354.
21. Keilholz U., Menssen H. D., Gaiger A., Menke A., Oji Y., Oka Y., Scheibenbogen C., Stauss H., Thiel E. and Sugiyama H. (2005) Wilms' tumour gene 1 (WT1) in human neoplasia. Leukemia 19, 1318-1323.
22. Klempt M., Klempt N. D. and Gluckman P. D. (1993) Hypoxia and hypoxia/ischemia affect the expression of insulin-like growth factor binding protein 2 in the developing rat brain. Brain Res. Mol. Brain Res. 17, 347-350.
23. Korsmeyer S. J. (1992) Bcl-2 initiates a new category of oncogenes: regulators of cell death. Blood 80, 879-886.
24. Kurihara S., Hakuno F. and Takahashi S. (2000) Insulin-like growth factor-I-dependent signal transduction pathways leading to the induction of cell growth and differentiation of human neuroblastoma cell line SH-SY5Y: the roles of MAP kinase pathway and PI 3-kinase pathway. Endocr. J. 47, 739-751.
25. LeRoith D., Werner H., Beitner-Johnson D. and Roberts C. T. Jr (1995) Molecular and cellular aspects of the insulin-like growth factor I receptor. Endocr. Rev. 16, 143-163.
26. Liu X. W., Gong L. J., Guo L. Y., Katagiri Y., Jiang H., Wang Z. Y., Johnson A. C. and Guroff G. (2001) The Wilms' tumor gene product WT1 mediates the down-regulation of the rat epidermal growth factor receptor by nerve growth factor in PC12 cells. J. Biol. Chem. 276, 5068-5073.
27. Lovell M. A., Xie C., Xiong S. and Markesbery W. R. (2003) Wilms' tumor suppressor (WT1) is a mediator of neuronal degeneration associated with the pathogenesis of Alzheimer's disease. Brain Res. 983, 84-96.
28. Maheswaran S., Englert C., Bennett P., Heinrich G. and Haber D. A. (1995) The WT1 gene product stabilizes p53 and inhibits p53-mediated apoptosis. Genes Dev. 9, 2143-2156.
29. Mayo M. W., Wang C.-Y., Drouin S. S., Madrid L. V., Marshall A. F., Reed J. C., Weissman B. E. and Baldwin A. S. (1999) WT1 modulates apoptosis by transcriptionally upregulating the bcl-2 proto-oncogene. EMBO J. 18, 3990-4003.
30. McConnell M. J., Cunliffe H. E., Chua L. J., Ward T. A. and Eccles M. R. (1997) Differential regulation of the human Wilms tumour suppressor gene (WT1) promoter by two isoforms of PAX2. Oncogene 1, 2689-2700.
31. Murata Y., Kudoh T., Sugiyama H., Toyoshima K. and Akiyama T. (1997) The Wilms tumor suppressor gene WT1 induces G1 arrest and apoptosis in myeloblastic leukemia M1 cells. FEBS Lett. 409, 41-45.
32. Nordqvist A. C., Holmin S., Nilsson M., Mathiesen T. and Schalling M. (1997) MK-801 inhibits the cortical increase in IGF-1, IGFBP-2 and IGFBP-4 expression following trauma. Neuroreport 8, 455-460.
33. Obermeier A., Bradshaw R. A., Seedorf K., Choidas A., Schlessinger J. and Ullrich A. (1994) Neuronal differentiation signals are controlled by nerve growth. EMBO J. 13, 1585-1590.
34. Raile K., Hille R., Laue S., Schulz A., Pfeifer G., Horn F. and Kiess W. (2003) Insulin-like growth factor I (IGF-I) stimulates proliferation but also increases caspase-3 activity, Annexin-V binding, and DNA-fragmentation in human MG63 osteosarcoma cells: co-activation of pro- and anti-apoptotic pathways by IGF-I. Horm. Metab. Res. 357, 86-973.
35. Rauscher F. J. III (1993) The WT1 Wilms tumor gene product: a developmentally regulated transcription factor in the kidney that functions as a tumor suppressor. FASEB J. 7, 896-903.
36. Rauscher F. J. III, Morris J. F., Tournay O. E., Cook D. M. and Curran T. (1990) Binding of the Wilms' tumor locus zinc finger protein to the EGR-1 consensus sequence. Science 250, 1259-1262.
37. Reed J. C. (1997) Double identity for proteins of the Bcl-2 family. Nature 387, 773-776.
38. Rubin R. and Baserga R. (1995) Insulin-like growth factor-I receptor. Its role in cell proliferation, apoptosis, and tumorigenicity. Laboratory Invest. 73, 311-331.
39. Saile B., DiRocco P., Dudas J., El-Armouche H., Sebb H., Eisenbach C., Neubauer K. and Ramadori G. (2004) IGF-I induces DNA synthesis and apoptosis in rat liver hepatic stellate cells (HSC) but DNA synthesis and proliferation in rat liver myofibroblasts (rMF). Laboratory Invest. 84, 1037-1049.
40. Seto J., Seto Y., Iino M., Komatsu T., Katagiri K., Hagino A., Aso H., Katoh K., Sasaki Y. and Obara Y. (2001) IGF-I-induced apoptosis in LM2d6 cultured at a low concentration of fetal bovine serum. Cell Biol. Int. 25, 893-899.
41. Thompson C. B. (1995) Apoptosis in the pathogenesis and treatment of disease. Science 267, 1456-1462.
42. Wagner N., Wagner K. D., Schley G., Coupland S. E., Heimann H., Grantyn R. and Scholz H. (2002) The Wilms' tumor suppressor Wt1 is associated with the differentiation of retinoblastoma cells. Cell Growth Differ. 13, 297-305.
43. Walter H. J., Berry M., Hill D. J. and Logan A. (1997) Spatial and temporal changes in the insulin-like growth factor (IGF) axis indicate autocrine/paracrine actions of IGF-I within wounds of the rat brain. Endocrinology 138, 3024-3034.
44. Wang Z. Y., Madden S. L., Deuel T. F. and Rauscher F. J. III (1992) The Wilms' tumor gene product, WT1, represses transcription of the platelet-derived growth factor A-chain gene. J. Biol. Chem. 267, 21 999-22 002.
45. Werner H., Bach M. A., Stannard B., Roberts C. T. and LeRoith D Jr . (1992) Structural and functional analysis of the insulin-like growth factor I receptor gene promoter. Mol. Endocrinol. 6, 1545-1558.
46. Werner H., Re G. G., Drummond I. A., Sukhatme V. P., Rauscher F. J. III, Sens D. A., Garvin A. J., LeRoith D Jr. and Roberts C. T. (1993) Increased expression of the insulin-like growth factor-I receptor gene, IGFIR, in Wilms' tumor is correlated with modulation of IGFIR promoter activity by the WT1 Wilms' tumor gene product. Proc. Natl. Acad. Sci. USA 90, 5828-5832.
47. Werner H., Adamo M., Roberts C. T. and LeRoith D. Jr (1994) Molecular and cellular aspects of insulin-like growth factor action, in Vitamins and Hormones (Vol. 48, Litwack G., ed.), pp. 1-58. Academic Press, San Diego.
48. Werner H., Shen-Orr Z., Rauscher F. J. III, Morris J. F., Roberts C. T. and LeRoith D. Jr (1995) Inhibition of cellular proliferation by the Wilms' tumor suppressor WT1 is associated with suppression of insulin-like growth factor I receptor gene expression. Mol. Cell. Biol. 15, 3516-3522.
49. Zhong J., Deng J., Ghetti B. and Lee W. H. (2002) Inhibition of insulin-like growth factor I activity contributes to the premature apoptosis of cerebellar granule neuron in weaver mutant mice: in vitro analysis. J. Neurosci. Res. 70, 36-45.
50. Zumkeller W. (2002a) IGFs and IGF-binding proteins as diagnostic markers and biological modulators in brain tumors. Expert. Rev. Mol. Diagn. 5, 473-477.
51. Zumkeller W. (2002b) The insulin-like growth factor system in hematopoietic cells. Leuk. Lymphoma 43, 487-491.